Bliss GVS Pharma Ltd.
| BSE: 506197 | Sector: Health care |
| NSE: BLISSGVS | ISIN Code: INE416D01022 |
| BSE 00:00 | 24 Jun | 110.45 |
0.40 (0.36%) |
OPEN
111.45 |
HIGH
111.50 |
LOW
109.20 |
| NSE 00:00 | 24 Jun | 110.55 |
0.60 (0.55%) |
OPEN
110.10 |
HIGH
111.55 |
LOW
109.30 |
| OPEN | 111.45 |
| PREVIOUS CLOSE | 110.05 |
| VOLUME | 55652 |
| 52-Week high | 224.00 |
| 52-Week low | 91.50 |
| P/E | 16.91 |
| Mkt Cap.(Rs cr) | 1,142 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bliss GVS Pharma Ltd. (BLISSGVS) - Announcements
-
Bliss GVS Pharma Ltd Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange
10/06/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
19/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
15/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Contact Details Of Kmps For Reporting Of Material Events
12/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Declaration Of Not Debarred From Holding The Office Of Director For Appointment Of Mr. Gagan Harsh S
12/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Allotment
11/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Dividend Updates
11/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Change in Directorate
11/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended
11/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
05/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Board Meeting Intimation for Board Meeting Intimation To Consider Audited Standalone And Consolidate
03/05/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligation
29/04/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Certificate Under Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations
29/04/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Shareholding for the Period Ended March 31 2021
20/04/2021 | bse
-
Bliss GVS Pharma Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
20/04/2021 | bse
-
Bliss GVS Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
14/04/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019
06/04/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Clarification On Price Movement
01/04/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Clarification sought from Bliss GVS Pharma Ltd
01/04/2021 | bse
-
Bliss GVS Pharma Ltd Closure of Trading Window
31/03/2021 | bse |
Downlaod PDF
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
